Impact of commonly used transplant immunosuppressive drugs on human NK cell function is dependent upon stimulation condition

Research output: Contribution to journalArticleResearchpeer-review

33 Citations (Scopus)


Lung transplantation is a recognised treatment for patients with end stage pulmonary disease. Transplant recipients receive life-long administration of immunosuppressive drugs that target T cell mediated graft rejection. However little is known of the impact on NK cells, which have the potential to be alloreactive in response to HLA-mismatched ligands on the lung allograft and in doing so, may impact negatively on allograft survival. NK cells from 20 healthy controls were assessed in response to Cyclosporine A, Mycophenolic acid (MPA; active form of Mycophenolate mofetil) and Prednisolone at a range of concentrations. The impact of these clinically used immunosuppressive drugs on cytotoxicity (measured by CD107a expression), IFN-? production and CFSE proliferation was assessed in response to various stimuli including MHC class-I negative cell lines, IL-2/IL-12 cytokines and PMA/Ionomycin. Treatment with MPA and Prednisolone revealed significantly reduced CD107a expression in response to cell line stimulation. In comparison, addition of MPA and Cyclosporine A displayed reduced CD107a expression and IFN-? production following PMA/Ionomycin stimulation. Diminished proliferation was observed in response to treatment with each drug.
Original languageEnglish
Article numbere60144
Number of pages10
JournalPLoS ONE
Issue number3
Publication statusPublished - 2013

Cite this